Hear from our CEO, Adrian Treverton, about treating non-melanoma skin cancer patients safely during COVID. Patients most likely to develop basal or squamous cell carcinoma are those in the age range at greater risk of serious illness from COVID, so safe and short treatment options are important.
SPOTLIGHT: Characterization and Biological Validation of Photon FLASH
SPOTLIGHT: Characterization and Biological Validation of Photon FLASH FLASH (Ultra-High Dose Rate) Radiotherapy is an emerging cancer treatment modality that delivers radiation doses in milliseconds rather than minutes with a significant reduction in healthy tissue...




